Post-Acute COVID-19, Inflammation, and Depression

Summary

Single site, double blind, placebo-controlled, longitudinal study of depression in Subjects with COVID- 19 long haulers syndrome using a 1:1 ratio randomization for a single IV infusion of 6 million cells/kg allogeneic marrow stromal cells (MSCs).

Timeline

Start

2022-05-25

Primary completion

2023-12-20

Completion

2024-05-01

Outcome

Outcome not reported

Stopped: “Study never started”

Drugs

Indications